These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 12398889)

  • 1. Telomerase: a target for cancer therapeutics.
    Shay JW; Wright WE
    Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase inhibitors.
    White LK; Wright WE; Shay JW
    Trends Biotechnol; 2001 Mar; 19(3):114-20. PubMed ID: 11179805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Telomeres and telomerase as targeted therapies in cancer treatment].
    Souiden Y; Bouraoui A; Chaieb K; Mahdouani K
    Bull Cancer; 2010 Sep; 97(9):1087-104. PubMed ID: 20663741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase: a therapeutic target for the third millennium?
    Lavelle F; Riou JF; Laoui A; Mailliet P
    Crit Rev Oncol Hematol; 2000 May; 34(2):111-26. PubMed ID: 10799836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase inhibitors.
    Rowley PT; Tabler M
    Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere and telomerase in oncology.
    Mu J; Wei LX
    Cell Res; 2002 Mar; 12(1):1-7. PubMed ID: 11942406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting human telomerase by antisense oligonucleotides and ribozymes.
    Folini M; Pennati M; Zaffaroni N
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer.
    Sekhri K
    J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibition in cancer therapeutics: molecular-based approaches.
    Cunningham AP; Love WK; Zhang RW; Andrews LG; Tollefsbol TO
    Curr Med Chem; 2006; 13(24):2875-88. PubMed ID: 17073634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.
    Herbert BS; Wright AC; Passons CM; Wright WE; Ali IU; Kopelovich L; Shay JW
    J Natl Cancer Inst; 2001 Jan; 93(1):39-45. PubMed ID: 11136840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting telomerase for cancer therapeutics.
    Shay JW; Keith WN
    Br J Cancer; 2008 Feb; 98(4):677-83. PubMed ID: 18231105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere maintenance mechanisms as a target for drug development.
    Bearss DJ; Hurley LH; Von Hoff DD
    Oncogene; 2000 Dec; 19(56):6632-41. PubMed ID: 11426649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase as a therapeutic target. Therapeutic potential of telomerase inhibitors.
    Double JA
    Methods Mol Biol; 2002; 191():209-16. PubMed ID: 11951608
    [No Abstract]   [Full Text] [Related]  

  • 20. Telomere maintenance as a target for drug discovery.
    Sekaran V; Soares J; Jarstfer MB
    J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.